Skip to main content
. 2014 Mar 8;12:32. doi: 10.1186/1477-7525-12-32

Table 7.

Correlation between quality of life scores and the first two first axis of principal component analysis on prospective measures

Scores T1: baseline
T2: after surgery
T3: 3 months
T4: six months
First axis Second axis First axis Second axis First axis Second axis First axis Second axis
QLQ-C30 (N = 192)
 
 
 
 
 
 
 
 
GHS
-0.74
0.17
-0.72
-0.06
-0.79
-0.09
-0.79
0.03
Physical functioning
-0.76
-0.33
-0.76
0.01
-0.79
0.11
-0.81
0.03
Role functioning
-0.85
-0.22
-0.81
-0.05
-0.85
-0.05
-0.87
0.01
Emotional functioning
-0.46
0.71
-0.56
0.33
-0.68
0.31
0.73
0.23
Cognitive functioning
-0.57
0.34
-0.69
0.01
-0.67
0.34
-0.70
0.23
Social functioning
-0.71
-0.01
-0.70
0.13
-0.79
-0.01
-0.86
0.06
Fatigue
0.84
0.03
0.85
-0.01
0.90
0.02
0.87
0.02
Nausea and vomiting
0.63
0.01
0.56
0.18
0.46
0.70
0.40
0.69
Pain
0.77
0.19
0.81
0.07
0.69
-0.33
0.75
-0.02
Dyspnea
0.66
0.35
0.55
0.22
0.62
-0.14
0.67
-0.09
Insomnia
0.41
-0.63
0.54
-0.38
0.63
-0.15
0.63
-0.23
Appetite loss
0.51
-0.43
0.65
-0.11
0.61
0.46
0.48
0.66
Constipation
0.36
0.12
0.25
-0.42
0.44
0.37
0.42
0.25
Diarrhea
0.24
0.13
0.17
0.66
0.32
0.27
0.32
0.04
Financial difficulties
0.40
0.49
0.31
0.64
0.44
-0.11
0.38
-0.16
QLQ-BR23 (N = 154)
 
 
 
 
Body image
-0.70
0.47
-0.64
0.45
-0.79
0.07
-0.79
0.25
Sexual functioning
0.30
-0.44
0.24
-0.52
0.31
-0.51
0.41
-0.41
Future perspective
-0.31
0.46
-0.53
0.52
-0.76
0.25
-0.73
0.30
Systemic therapy side effects
0.78
-0.01
0.72
0.28
0.61
-0.49
0.67
-0.21
Breast symptoms
0.58
0.49
0.64
0.38
0.56
0.66
0.57
0.64
Arm symptoms 0.66 0.49 0.75 0.32 0.69 0.44 0.63 0.57